Although more speculative, it is worth noting that several of the genes preferentially mutated in long-term responders, such as COCH or SPON2, are involved in innate immune system modulation (42) and M2-polarized tumor-associated macrophage infiltration, suggesting that a disfunction in these genes might underlie clinical benefit in this subgroup. The gene discussed is COCH; the disease is neoplasm.